ProMRI 3T ENHANCED Master Study

CompletedOBSERVATIONAL
Enrollment

129

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

January 15, 2018

Study Completion Date

January 15, 2018

Conditions
Safety of MR (Magnetic Resonance)-Conditional ICDs
Interventions
DEVICE

Implantable Cardioverter Defibrillator therapy

Tachycardia Fast Heart Beat

OTHER

Magnetic Resonance Imaging (MRI)

MRI scan of the head and lower body parts

Trial Locations (12)

Unknown

Flinders Medical Centre, Bedford Park

Royal North Shore Hospital, Sydney

Westmead Hospital, Westmead

Allgemeines Krankenhaus Linz, Linz

Landesklinikum St. Pölten, Sankt Pölten

Deutsches Herzzentrum Berlin, Berlin

Klinikum Coburg, Coburg

Uniklinikum Düsseldorf, Düsseldorf

Universitätsklinikum Göttingen, Göttingen

St. Bonifatius Hospital, Lingen

National Heart Centre, Singapore

Stadtspital Triemli, Zurich

All Listed Sponsors
lead

Biotronik SE & Co. KG

INDUSTRY

NCT02506569 - ProMRI 3T ENHANCED Master Study | Biotech Hunter | Biotech Hunter